A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)

Clinical trial NCT02092935 · COMPLETED

Trial details

NCT number: NCT02092935
Sponsor: Summit Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2014-04-01
Primary completion: 2015-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.